secwatch.observer — SEC 8-K summary
======================================

Issuer:     NRC HEALTH (NRC)
CIK:        0000070487
Form:       8-K
Filed at:   2023-05-04T23:59:59+00:00
Accession:  0001437749-23-012493
Event type: earnings
Sentiment:  negative
Materiality: 0.55
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

National Research Q1 EPS falls to $0.28 from $0.34; capital allocation unchanged
--------------------------------------------------------------------------------

- Diluted EPS $0.28 for Q1 2023, down from $0.34 in Q1 2022.
- Company funded $2.9M for innovation and growth, $3.0M for dividends, $2.0M for share repurchases.
- Board maintains capital allocation priorities: innovation, M&A, dividends, buybacks.
- Announced MyView to integrate patient insights into EHR to support personalized care.
- Expanding sales and marketing resources for Human Understanding Program.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/70487/000143774923012493/0001437749-23-012493-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/70487/000143774923012493/nrc20230503_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-23-012493

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer